Prevalence of the human papillomavirus (HPV) types among cervical dysplasia women attending a gynaecological clinic in Sweden

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  P. Lopalco,et al.  The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019) , 2020, Expert review of vaccines.

[3]  M. Poljak,et al.  The European response to the WHO call to eliminate cervical cancer as a public health problem , 2020, International journal of cancer.

[4]  Chengquan Zhao,et al.  HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory. , 2020, Journal of the American Society of Cytopathology.

[5]  P. Sparén,et al.  Impact of HPV vaccination on cervical screening performance: a population-based cohort study , 2020, British Journal of Cancer.

[6]  S. Regauer,et al.  Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study. , 2020, Gynecologic oncology.

[7]  M. Karlsson,et al.  Prevalence of HPV and pathological changes among women 70 years of age, 10 years after exclusion from the Swedish cervical cancer screening program , 2020, Cancer Causes & Control.

[8]  Maria Hortlund,et al.  Human papillomavirus types in cervical dysplasia among young HPV‐vaccinated women: Population‐based nested case–control study , 2019, International journal of cancer.

[9]  R. Olsen,et al.  HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests. , 2019, Journal of the American Society of Cytopathology.

[10]  L. Engstrand,et al.  Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine , 2019, Front. Cell. Infect. Microbiol..

[11]  Maria Hortlund,et al.  Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention , 2019, Cancer medicine.

[12]  S. Beddows,et al.  The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010–2016 , 2018, The Journal of infectious diseases.

[13]  T. Iftner,et al.  Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers , 2017, Papillomavirus research.

[14]  R. Winer,et al.  Natural History of HPV Infection across the Lifespan: Role of Viral Latency , 2017, Viruses.

[15]  A. Firenze,et al.  Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily , 2017, Human vaccines & immunotherapeutics.

[16]  J. Ordi,et al.  HPV‐negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis , 2015, BJOG : an international journal of obstetrics and gynaecology.

[17]  S. Franceschi,et al.  A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. , 2013, Virology.

[18]  W. Tjalma,et al.  Cervical cancer screening: which HPV test should be used--L1 or E6/E7? , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[19]  M. Plummer,et al.  Global burden of human papillomavirus and related diseases. , 2012, Vaccine.

[20]  Peng Guan,et al.  Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer , 2012, International journal of cancer.

[21]  C. Rubio,et al.  Prevalence of Human Papillomavirus (HPV) in Oesophageal Squamous Cell Carcinoma in Relation to Anatomical Site of the Tumour , 2012, PloS one.

[22]  E. Lynge,et al.  Introduction of human papillomavirus vaccination in Nordic countries. , 2012, Vaccine.

[23]  P. Sparén,et al.  Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15–23-year-old women attending a youth health clinic in Stockholm, Sweden , 2011, Scandinavian journal of infectious diseases.

[24]  J. Dillner,et al.  Introduction of human papillomavirus (HPV) vaccination in Sweden. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[25]  S. Franceschi,et al.  Human papillomavirus types in glandular lesions of the cervix: A meta‐analysis of published studies , 2013, International journal of cancer.

[26]  The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. , 1989, JAMA.